Stocks

Stock Market News

20 stories
zacks

Atlassian Stock Plunges 46% in 6 Months: Time to Hold Steady or Exit?

Atlassian Corporation TEAM shares have plummeted 45.6% in the trailing six-month period, underperforming the broader Zacks Computer and Technology sector’s rise of 15.7% and the Zacks Internet - Software industry’s decline of 8.1%.The underperformance can be attributed to investor concerns over AI…

Zacks en
StocksUS

Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Gerresheimer AGGerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution03.07.2026 / 14:28 CET/CESTDissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group.The issu…

EQS en
ETFsStocksDE
zacks

Dow Hits 21st All-Time Closing High in 2026: Buy These 3 Stocks

Wall Street has turned volatile over the past two weeks, led by a massive tech selloff. However, the Dow has had a solid run this year, with the blue-chip index hitting a new all-time closing high on Thursday.After a stellar first half of 2026, the Dow started the second half on a high, thanks to i…

Zacks en
indexStocksUS
zacks

PepsiCo Q2 Earnings Preview: Buy, Hold or Sell the Stock?

PepsiCo, Inc. PEP is expected to register top and bottom-line growth when it reports second-quarter 2026 numbers on July 9, before the opening bell.The Zacks Consensus Estimate for second-quarter revenues is pegged at $23.9 billion, implying 5% growth from the year-ago quarter's reported figure. Fo…

Zacks en
StocksUS
zacks

KNSL Stock Trades Above 50-Day SMA: What Should Investors Do?

Kinsale Capital Group, Inc. KNSL has been trading above its 50-day simple moving average (SMA), signaling a short-term bullish trend. Its share price, as of July 2, 2026, was $354.85, down 30.8% from its 52-week high of $512.76.The 50-day SMA is a key indicator for traders and analysts to identify…

Zacks en
StocksUS
sharecast

Ilika raises £4.56m in placing, seeks another £0.5m through retail offer

The AIM-traded solid-state battery developer said the shares were issued at 28p each, a 3.45% discount to Wednesday’s closing price, with the proceeds to support the commercial rollout and scaling of its small-format Stereax technology and continued development of its larger-format Goliath platform…

ShareCast en
ETFsStocksGB

REG - Barclays PLC Treatt PLC - Form 8.3 TREATT PLC

RNS Number : 9986K Barclays PLC 03 July 2026  This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distri…

London Stock Exchange en
StocksGBUS
modular_finance

Ascelia Pharma provides update on the Orviglance NDA

Ascelia Pharma AB (publ) (ticker: ACE), a biotechnology company focused on improving the lives of people living with rare cancer conditions, today announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the Company's New Drug Applic…

MFN by Modular Finance en
StocksSE

Elmos Semiconductor SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Elmos Semiconductor SEElmos Semiconductor SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution03.07.2026 / 14:22 CET/CESTDissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS…

EQS en
StocksDE
NEWS dpa_afx

Potential Treatments Trial For Ebola Virus Begins In DR Congo: WHO

WASHINGTON (dpa-AFX) - In a major international effort to evaluate potential treatments for Ebola disease due to Bundibugyo virus (BVD), the PARTNERS clinical trial has opened enrolment for patients in the Democratic Republic of the Congo.The PARTNERS (Platform Adaptive Randomised Trial for New and…

dpa-AFX en
StocksUS

European Investors Want to Look Beyond AI — Market Talk

European equity investors want to broaden their holdings beyond artificial intelligence-linked stocks, Morgan Stanley analysts write. Investors should look to broaden into stocks that aren't dependent on AI and those which provide income in order to reduce volatility in their portfolios, the analys…

Dow Jones Newswires en
StocksGB
tradingview

Stellantis N.V. Stock 12‑Month Price Target Cut to $8.27, Implies 42% Upside

Explore more price target data and ratings for Stellantis N.V. on the Forecasts tab, and track all previous and future analyst recommendations for Stellantis N.V. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is…

TradingView en
StocksUS